Antitumor agent-88
Antitumor agent-88 exhibits potent antimitotic activity and arrests cell in the G2/M phase. Antitumor agent-88 disrupts the microtubule and the cytoskeleton in CYP1A1-expressing breast cancer cells. Antitumor agent-88 is also a competitive inhibitor of CYP1A1 (Ki: 1.4 μM) [1].
Product Specifications
CAS Number
1422527-87-4
UNSPSC
12352005
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antitumor-agent-88.html
Solubility
10 mM in DMSO
Smiles
CCCCCN1CCN(C2=CC=C(S(=O)(OC3=CC(OC)=C(C(OC)=C3)OC)=O)C=C2)C1=O
Molecular Formula
C23H30N2O7S
Molecular Weight
478.56
References & Citations
[1]Chavez Alvarez AC, et al. Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4- (2-Oxo-3-alkylimidazolidin-1-yl) benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver Microsomes. J Med Chem. 2023 Feb 23;66 (4) :2477-2497.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx018166 100 µg
Transformation Up-Regulated Nuclear Protein (TUNP) Antibody
Sign In for Pricing
View Details 